CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Planned sale CHIEF EXECUTIVE OFFICER sold 24,461 shares at an average $52.50 ($1,284,205)
- 4 Planned sale PRESIDENT AND CFO sold 10,000 shares at $53.00 ($530,000)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,194 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 4 Grant or award Director acquired 2,265 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Planned sale CHIEF OPERATING OFFICER sold 2,250 shares at an average $49.52 ($111,416)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 4 of 39 · 770 filings